These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2569409)

  • 1. Dopamine receptors in the stellate ganglion of the dog.
    Kohli JD; Metra M; Satoh Y; Goldberg LI
    Eur J Pharmacol; 1989 May; 164(2):265-72. PubMed ID: 2569409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopamine receptor and alpha 2-adrenoceptor agonists and antagonists on muscarinic receptor stimulation in cardiac sympathetic ganglia of the dog.
    Kimura T; Mukaiyama O; Satoh S
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):382-6. PubMed ID: 1378118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart.
    Dlewati A; Watkins HO; Lokhandwala MF
    Eur J Pharmacol; 1989 May; 164(2):197-203. PubMed ID: 2569408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD; Glock D; Goldberg LI
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits.
    Szabo B; Hedler L; Starke K
    J Pharmacol Exp Ther; 1986 Dec; 239(3):881-6. PubMed ID: 2879034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S; Lokhandwala MF
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
    Rump LC; Schwertfeger E; Schuster MJ; Schaible U; Frankenschmidt A; Schollmeyer PJ
    Kidney Int; 1993 Jan; 43(1):197-204. PubMed ID: 8094472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopaminergic drugs on the sympathoadrenal system.
    Damase-Michel C; Montastruc JL; Tran MA
    Hypertens Res; 1995 Jun; 18 Suppl 1():S119-24. PubMed ID: 8529040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
    Semeraro C; Ferrini R; Allievi L; Pocchiari F; Nicosia S; Casagrande C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):539-46. PubMed ID: 1982561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
    Clark KL; Robertson MJ; Drew GM
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.